128 related articles for article (PubMed ID: 27830964)
1. Fcγ receptor 3B polymorphism is associated with hypersensitivity reactions to adalimumab in Japanese patients with rheumatoid arthritis.
Tsukamoto M; Kameda H; Ohshige T; Kaneko Y; Yoshimoto K; Suzuki K; Takeuchi T
Mod Rheumatol; 2017 Sep; 27(5):778-781. PubMed ID: 27830964
[TBL] [Abstract][Full Text] [Related]
2. Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis.
Okuyama A; Nagasawa H; Suzuki K; Kameda H; Kondo H; Amano K; Takeuchi T
Ann Rheum Dis; 2011 Feb; 70(2):299-304. PubMed ID: 20980704
[TBL] [Abstract][Full Text] [Related]
3. Impact of FCGR2A R131H, FCGR3A F158V and FCGR3B NA1/NA2 polymorphisms on response to Fc-containing TNF inhibitors in Tunisian rheumatoid arthritis patients.
Mahmoud I; Moalla M; Ben Tekaya A; Bouden S; Rouached L; Tekaya R; Saidane O; Gorji Y; Elleuch M; Laatar A; Hamdi W; Abdelmoula L; Sfar I
Drug Metab Pers Ther; 2023 Jun; 38(2):155-162. PubMed ID: 36919284
[TBL] [Abstract][Full Text] [Related]
4. NA1/NA2 heterozygote of Fcgr3b is a risk factor for progression of IgA nephropathy in Chinese.
Xu G; He Q; Shou Z; Wang H; Zhang X; Wang Y; Chen Y; Chen J
J Clin Lab Anal; 2007; 21(5):298-302. PubMed ID: 17847104
[TBL] [Abstract][Full Text] [Related]
5. Impact of allele copy number of polymorphisms in FCGR3A and FCGR3B genes on susceptibility to ulcerative colitis.
Asano K; Matsumoto T; Umeno J; Hirano A; Esaki M; Hosono N; Matsui T; Kiyohara Y; Nakamura Y; Kubo M; Kitazono T
Inflamm Bowel Dis; 2013 Sep; 19(10):2061-8. PubMed ID: 23917248
[TBL] [Abstract][Full Text] [Related]
6. Association of rheumatoid factor production with FcgammaRIIIa polymorphism in Taiwanese rheumatoid arthritis.
Chen JY; Wang CM; Wu JM; Ho HH; Luo SF
Clin Exp Immunol; 2006 Apr; 144(1):10-6. PubMed ID: 16542359
[TBL] [Abstract][Full Text] [Related]
7. Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus.
Morris DL; Roberts AL; Witherden AS; Tarzi R; Barros P; Whittaker JC; Cook TH; Aitman TJ; Vyse TJ
Eur J Hum Genet; 2010 Sep; 18(9):1027-31. PubMed ID: 20442749
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil role in in vivo anti-lymphoma activity of rituximab: FCGR3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatment.
Cartron G; Ohresser M; Salles G; Solal-Céligny P; Colombat P; Watier H
Ann Oncol; 2008 Aug; 19(8):1485-1487. PubMed ID: 18408222
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study and Fcgamma receptor gene analysis in two patients with rheumatoid arthritis controlled by low-dose infliximab.
Nishio S; Yamamoto T; Kaneko K; Tanaka-Matsumoto N; Muraoka S; Kaburaki M; Kusunoki Y; Takagi K; Kawai S
Mod Rheumatol; 2009; 19(3):329-33. PubMed ID: 19255827
[TBL] [Abstract][Full Text] [Related]
10. Associations between FCGR2A rs1801274, FCGR3A rs396991, FCGR3B NA1/NA2 polymorphisms and periodontitis: a meta-analysis.
Song GG; Lee YH
Mol Biol Rep; 2013 Aug; 40(8):4985-93. PubMed ID: 23649770
[TBL] [Abstract][Full Text] [Related]
11. Fcγ receptor IIIb (CD16b) polymorphisms are associated with susceptibility to idiopathic pulmonary fibrosis.
Bournazos S; Bournazou I; Murchison JT; Wallace WA; McFarlane P; Hirani N; Simpson AJ; Dransfield I; Hart SP
Lung; 2010 Dec; 188(6):475-81. PubMed ID: 20924590
[TBL] [Abstract][Full Text] [Related]
12. FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritis.
Dávila-Fajardo CL; van der Straaten T; Baak-Pablo R; Medarde Caballero C; Cabeza Barrera J; Huizinga TW; Guchelaar HJ; Swen JJ
Pharmacogenomics; 2015; 16(4):373-81. PubMed ID: 25823785
[TBL] [Abstract][Full Text] [Related]
13. Distribution of FcgammaRIIa and FcgammaRIIIb genotypes in patients with generalized aggressive periodontitis.
de Souza RC; Colombo AP
J Periodontol; 2006 Jul; 77(7):1120-8. PubMed ID: 16805673
[TBL] [Abstract][Full Text] [Related]
14. Genetic risk factors for infection in patients with early rheumatoid arthritis.
Hughes LB; Criswell LA; Beasley TM; Edberg JC; Kimberly RP; Moreland LW; Seldin MF; Bridges SL
Genes Immun; 2004 Dec; 5(8):641-7. PubMed ID: 15526004
[TBL] [Abstract][Full Text] [Related]
15. FcgammaRIIa, IIIa and IIIb gene polymorphisms in Behçet's disease: do they have any clinical implications?
Aksu K; Kitapcioglu G; Keser G; Berdeli A; Karabulut G; Kobak S; Ozmen M; Inal V; Kabasakal Y; Oksel F; Kocanaogullari H; Doganavsargil E
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S77-83. PubMed ID: 19026120
[TBL] [Abstract][Full Text] [Related]
16. Understanding the Genomic Structure of Copy-Number Variation of the Low-Affinity Fcγ Receptor Region Allows Confirmation of the Association of FCGR3B Deletion with Rheumatoid Arthritis.
Rahbari R; Zuccherato LW; Tischler G; Chihota B; Ozturk H; Saleem S; Tarazona-Santos E; Machado LR; Hollox EJ
Hum Mutat; 2017 Apr; 38(4):390-399. PubMed ID: 27995740
[TBL] [Abstract][Full Text] [Related]
17. Fc γ receptor IIIB (FcγRIIIB) polymorphisms are associated with clinical malaria in Ghanaian children.
Adu B; Dodoo D; Adukpo S; Hedley PL; Arthur FK; Gerds TA; Larsen SO; Christiansen M; Theisen M
PLoS One; 2012; 7(9):e46197. PubMed ID: 23049979
[TBL] [Abstract][Full Text] [Related]
18. Association between Fcγ receptor IIA, IIIA and IIIB genetic polymorphisms and susceptibility to severe malaria anemia in children in western Kenya.
Munde EO; Okeyo WA; Raballah E; Anyona SB; Were T; Ong'echa JM; Perkins DJ; Ouma C
BMC Infect Dis; 2017 Apr; 17(1):289. PubMed ID: 28427365
[TBL] [Abstract][Full Text] [Related]
19. New adalimumab formulation associated with less injection site pain and improved motivation for treatment.
Yoshida T; Otaki Y; Katsuyama N; Seki M; Kubota J
Mod Rheumatol; 2019 Nov; 29(6):949-953. PubMed ID: 30183438
[No Abstract] [Full Text] [Related]
20. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility.
Kyogoku C; Dijstelbloem HM; Tsuchiya N; Hatta Y; Kato H; Yamaguchi A; Fukazawa T; Jansen MD; Hashimoto H; van de Winkel JG; Kallenberg CG; Tokunaga K
Arthritis Rheum; 2002 May; 46(5):1242-54. PubMed ID: 12115230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
